Acid inhibitory medication and risk of gastric and oesophageal cancer (Q35769164)

10 August 2017

1 reference

title

Acid inhibitory medication and risk of gastric and oesophageal cancer (English)

1 reference

10 August 2017

K E L McColl

1

1 reference

PubMed ID

17047103

10 August 2017

language of work or name

English

0 references

publication date

1 November 2006

1 reference

10 August 2017

1 reference

10 August 2017

55

1 reference

10 August 2017

11

1 reference

10 August 2017

1532-1533

1 reference

Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860103

Cancer of the esophagus and gastric cardia: recent advances

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860103

Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860103

Helicobacter pylori infection and the development of gastric cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860103

Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860103

Campylobacter pyloridis, gastritis, and peptic ulceration

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860103

Hiatal hernia, reflux symptoms, body size, and risk of esophageal and gastric adenocarcinoma

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860103

Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860103

The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860103

Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma

25 September 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860103

23 October 2018

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860103

Gastric acidity before and after the development of carcinoma of the stomach

6 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17047103

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17047103

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Gastric acidity before and after development of gastric cancer: its etiologic, diagnostic and prognostic significance

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17047103

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/GUT.2006.103283

1 reference

10 August 2017

1 reference

10 August 2017

1 reference

PubMed ID

17047103